Urethra-Sparing, Intraoperative, Real-Time Planned, Permanent-Seed Prostate Brachytherapy: Toxicity Analysis
详细信息    查看全文
文摘

Purpose

To report the toxicity outcome in patients with localized prostate cancer undergoing 125I permanent-seed brachytherapy (BT) according to a urethra-sparing, intraoperative (IO), real-time planned conformal technique.

Methods and Materials

Data were analyzed on 250 patients treated consecutively for low- or intermediate-risk prostate cancer between 2005 and 2009. The planned goal was urethral V150?= 0. Acute and late genitourinary (GU), gastrointestinal (GI), and erectile toxicities were scored with the International Prostate Symptom Score (IPSS) questionnaire and Common Terminology Criteria for Adverse Events (version 3.0). Median follow-up time for patients with at least 2 years of follow-up (n?= 130) was 34.4 months (range, 24?6.9 months).

Results

Mean IO urethra V150 was 0.018 % ¡À 0.08 % . Mean prostate D90 and V100 on day-30 computed tomography scan were 158.0 ¡À 27.0 Gy and 92.1 % ¡À 7.2 % , respectively. Mean IPSS peak was 9.5 ¡À 6.3 1 month after BT (mean difference from baseline IPSS, 5.3). No acute GI toxicity was observed in 86.8 % of patients. The 3-year probability of Grade ? late GU toxicity-free survival was 77.4 % ¡À 4.0 % , with Grade 3 late GU toxicity encountered in only 3 patients. Three-year Grade 1 late GI toxicity-free survival was 86.1 % ¡À 3.2 % . No patient presented Grade ? late GI toxicity. Of patients with normal sexual status at baseline, 20.7 % manifested Grade ? erectile dysfunction after BT. On multivariate analysis, elevated baseline IPSS (p?= 0.016) and high-activity sources (median 0.61 mCi) (p?= 0.033) predicted increased Grade ? late GU toxicity.

Conclusions

Urethra-sparing IO BT results in low acute and late GU toxicity compared with the literature. High seed activity and elevated IPSS at baseline increased long-term GU toxicity.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700